India Markets close in 34 mins
  • BSE SENSEX

    44,684.77
    +535.05 (+1.21%)
     
  • Nifty 50

    13,114.30
    +145.35 (+1.12%)
     
  • USD/INR

    73.5550
    -0.4350 (-0.5879%)
     
  • Dow

    29,638.64
    -271.73 (-0.91%)
     
  • Nasdaq

    12,198.74
    -7.11 (-0.06%)
     
  • BTC-INR

    1,434,298.50
    -1,294.88 (-0.09%)
     
  • CMC Crypto 200

    383.79
    +19.20 (+5.27%)
     
  • Hang Seng

    26,567.68
    +226.19 (+0.86%)
     
  • Nikkei

    26,787.54
    +353.92 (+1.34%)
     
  • EUR/INR

    88.1059
    -0.2078 (-0.24%)
     
  • GBP/INR

    98.4079
    -0.2026 (-0.21%)
     
  • AED/INR

    19.9850
    -0.1200 (-0.60%)
     
  • INR/JPY

    1.4139
    +0.0061 (+0.43%)
     
  • SGD/INR

    54.9100
    -0.2800 (-0.51%)
     

Moderna to Charge $25-$37 for Covid-19 Vaccine, Close to Striking Deal with EU

News18
·1-min read

Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).

“Our vaccine therefore costs about the same as a flu shot, which is between $10 and $50,” he was quoted as saying.

On Monday, an EU official involved in the talks said the European Commission wanted to reach a deal with Moderna for the supply of millions of doses of its vaccine candidate for a price below $25 per dose.

“Nothing is signed yet, but we’re close to a deal with the EU Commission. We want to deliver to Europe and are in constructive talks,” Bancel told WamS, adding it was just a “matter of days” until a contract would be ready.

Moderna has said its experimental vaccine is 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial, becoming the second developer to report results that far exceeded expectations after Pfizer and its partner BioNTech.

The EU has been in talks with Moderna for its experimental COVID-19 vaccine at least since July.